Literature DB >> 22993535

Dietary factors, genetic and epigenetic influences in colorectal cancer.

M L Pellegrini1, P Argibay, D E Gomez.   

Abstract

Genetic influences, together with epigenetic components and dietary factors, play a fundamental role in the initiation and progression of cancer by causing a number of deregulations. Colorectal cancer (CRC) is a disease influenced by dietary factors, for which established genetic and epigenetic alterations have been identified. Within CRC, there are hereditary syndromes that present mutations in the germ-line hMLH1, and also alterations in the methylation of the promoters. Epigenetics has also been established as a pathway of carcinogenesis. In the present review, we analyzed studies conducted to discern the different pathways leading to established CRC, stressing the importance of identifying factors that may predict CRC at an early stage, since it is mostly a silent disease observed at the clinical level in advanced stages.

Entities:  

Year:  2010        PMID: 22993535      PMCID: PMC3445943          DOI: 10.3892/etm_00000038

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  111 in total

1.  Tumors with microsatellite instability: many mutations, targets and paradoxes.

Authors:  Manuel Perucho
Journal:  Oncogene       Date:  2003-04-17       Impact factor: 9.867

2.  A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk.

Authors:  J Ma; M J Stampfer; B Christensen; E Giovannucci; D J Hunter; J Chen; W C Willett; J Selhub; C H Hennekens; R Gravel; R Rozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

3.  Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2.

Authors:  T Moore; M Constancia; M Zubair; B Bailleul; R Feil; H Sasaki; W Reik
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

4.  Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.

Authors:  I Orlow; A Iavarone; S J Crider-Miller; F Bonilla; E Latres; M H Lee; W L Gerald; J Massagué; B E Weissman; C Cordón-Cardó
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

5.  Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.

Authors:  I Hatada; T Mukai
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

6.  Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.

Authors:  Marcia Cruz-Correa; Hengmi Cui; Francis M Giardiello; Neil R Powe; Linda Hylind; Angela Robinson; David F Hutcheon; David R Kafonek; Sheri Brandenburg; Yiqian Wu; Xiaobing He; Andrew P Feinberg
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

7.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

8.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

9.  Loss of p57KIP2 is associated with colorectal carcinogenesis.

Authors:  Jia-Qing Li; Fei Wu; Hisashi Usuki; Akihito Kubo; Tsutomu Masaki; Jiro Fujita; Shuji Bandoh; Kousuke Saoo; Hijiri Takeuchi; Shigeki Kuriyama; Toshihiko Ishida; Katsumi Imaida
Journal:  Int J Oncol       Date:  2003-12       Impact factor: 5.650

10.  Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.

Authors:  Adele Murrell; Yoko Ito; Gaetano Verde; Joanna Huddleston; Kathryn Woodfine; Margherita Cirillo Silengo; Filippo Spreafico; Daniela Perotti; Agostina De Crescenzo; Angela Sparago; Flavia Cerrato; Andrea Riccio
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  2 in total

1.  DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population.

Authors:  Abdolreza Daraei; Rasul Salehi; Faezeh Mohamadhashem
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

2.  Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.